•  
  •  
  •  
  •  

2026-08-11 01:01:06

  • Home
  • Commodities
  • Industry News
  • IPO
  • Mutual Funds
  • Others
  • Research
  • Watch List
Latest News
  • Lemon Tree Hotels signs Second hotel in Mcleodganj
  • Axis Mutual Fund launches Axis Nifty Energy Index Fund & Axis Nifty Energy ETF NFOs offering exposure to India's evolving capital energy ecosystem
  • Websol Energy Q1FY27 Revenue up 70% YoY at Rs 373 crore; Company Prepays Entire IREDA Term Loan
  • CPPIB to Invest ₹3,000 Crore in Prestige Estates' Hospitality Arm PHVL for Up to 28% Stake
  • Krystal Integrated Services Consortium Secures ₹740 Crore Urban Wastewater Contracts in Maharashtra

Keywords Selected:  UV

Stock Report

  • KP Energy Ltd inks PPA with GUVNL for 100 MW Grid Connected Wind Power Project
  • Powerica Limited Bags 100 MW Wind Power PPA from GUVNL
  • Sattrix Information Security Ltd receives order worth Rs. 1.74 crore
  • Nuvoco Vistas Net Profit Climbs 20% Year-on-Year to ₹159.63 Crore in Q1 FY27
  • Powerica Secures 50MW Wind Project bid from GUVNL's Wind Power Tender
  • Suven Life Sciences Approves INR 248 Crore Share Allotment, Board Re-appointment, and New Singapore Subsidiary
  • Sattrix Information Security Ltd secures order worth Rs. 9.30 crores
  • Sattrix Information Security Ltd receives orders worth Rs. 125.06 Mn
  • Mahindra Auto clocks 60,393 SUVs, a growth of 28% and 1,06,207 total vehicle sales, a growth of 37% in June 2026
  • The South Indian Bank Ltd to open new branch at Manavalanagar
  • SJVN signs PPAs with GUVNL for Supply of Green Power from Hydro Electric Projects in Himachal Pradesh
  • Suven Life Sciences to showcase its Differentiated CNS Clinical Candidates and Partnering Strategies at BIO International Convention 2026, 22-25, June 2026, San Diego, USA
  • Dhruva Capital Services Ltd announces launch of 'NeoMoney' Digital Lending Application on Google Play Store
  • Suven Life Sciences announces successful completion and topline results of First-in-Human (FIH) Phase-1 clinical study of SUVN-I6107
  • Suven Life Sciences announces three poster presentations on Samelisant (SUVN-G3031), including global Phase-3, AWAKE Narcolepsy Study at SLEEP-2026
  • Sattrix Information Security Ltd announces its Renewal Work Orders worth of Rs. 30.45 Millions in the month of April & May, 2026
  • Sattrix Information Security Ltd announces its Strategic Work Orders Worth of Rs. 65.02 Millions in April & May, 2026
  • Suven Life Sciences Reports Positive DSMB Safety Review and Interim Analysis from Ongoing Global Phase 3 Study of Masupirdine in Alzheimer's Disease
  • Advait BESS Bhesaan Pvt Ltd executes BESPA with GUVNL
  • Suven Life Sciences Reaches 76% Enrollment milestone in Global Phase 3 Masupirdine (SUVN-502) Trial for Agitation in Alzheimer's Dementia
  • Sattrix Software Solutions Pvt Ltd appoints distributor in UAE
  • KVB expands presence in Thirupuvanam
  • Karur Vysya Bank to Inaugurate 902nd Branch in Sivaganga District
  • Nuvoco Vistas Reports Stellar FY26 Results: Net Profit Surges to ₹359.77 Crore

Latest Post

  • Lemon Tree Hotels signs Second hotel in Mcleodganj
  • Axis Mutual Fund launches Axis Nifty Energy Index Fund & Axis Nifty Energy ETF NFOs offering exposure to India's evolving capital energy ecosystem
  • Websol Energy Q1FY27 Revenue up 70% YoY at Rs 373 crore; Company Prepays Entire IREDA Term Loan
  • CPPIB to Invest ₹3,000 Crore in Prestige Estates' Hospitality Arm PHVL for Up to 28% Stake
  • Krystal Integrated Services Consortium Secures ₹740 Crore Urban Wastewater Contracts in Maharashtra


Announcement

To Advertise in our website please e-mail us at advertisement@equitybulls.com
Companies can send their Press Releases to pressrelease@equitybulls.com

Links

  • Home
  • Contact
  • Our Team

Contact

The website is developed and maintained by Chennai Scripts
C-4, Podhigai Flats, Pillayar Koil Street, Nesapakkam
Chennai
Tamil Nadu
India
600078
E-mail: chennaiscripts@gmail.com
Mobile Phone Number: +91-88776-69935
www.chennaiscripts.com

Website Created & Maintained by : Chennai Scripts
Nesapakkam, Chennai - 600 078,
Tamil Nadu, India

Disclaimer Copyright © - 2025